Table of Contents
1 Market Overview
1.1 Short Bowel Syndrome (SBS) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Overview of Global Short Bowel Syndrome (SBS) Drugs Market
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sancilio Pharmaceuticals
2.2.1 Sancilio Pharmaceuticals Details
2.2.2 Sancilio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sancilio Pharmaceuticals SWOT Analysis
2.2.4 Sancilio Pharmaceuticals Product and Services
2.2.5 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ardelyx
2.3.1 Ardelyx Details
2.3.2 Ardelyx Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ardelyx SWOT Analysis
2.3.4 Ardelyx Product and Services
2.3.5 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 OxThera
2.5.1 OxThera Details
2.5.2 OxThera Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 OxThera SWOT Analysis
2.5.4 OxThera Product and Services
2.5.5 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Emmaus Medical
2.6.1 Emmaus Medical Details
2.6.2 Emmaus Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Emmaus Medical SWOT Analysis
2.6.4 Emmaus Medical Product and Services
2.6.5 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nutrinia
2.7.1 Nutrinia Details
2.7.2 Nutrinia Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nutrinia SWOT Analysis
2.7.4 Nutrinia Product and Services
2.7.5 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Naia Pharmaceuticals
2.8.1 Naia Pharmaceuticals Details
2.8.2 Naia Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Naia Pharmaceuticals SWOT Analysis
2.8.4 Naia Pharmaceuticals Product and Services
2.8.5 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Zealand Pharma
2.9.1 Zealand Pharma Details
2.9.2 Zealand Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Zealand Pharma SWOT Analysis
2.9.4 Zealand Pharma Product and Services
2.9.5 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.4 France Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.5 India Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2015-2020)
11 Global Short Bowel Syndrome (SBS) Drugs Market Segment by Application
11.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Short Bowel Syndrome (SBS) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Short Bowel Syndrome (SBS) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.2 Europe Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.4 South America Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.3 Short Bowel Syndrome (SBS) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Type (2021-2025)
12.4 Short Bowel Syndrome (SBS) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
Merck、Sancilio Pharmaceuticals、Ardelyx、Takeda、OxThera、Emmaus Medical、Nutrinia、Naia Pharmaceuticals、Zealand Pharma、
【免責事項】
https://www.globalresearch.jp/disclaimer